{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:33:53Z","timestamp":1789835633232,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010648","name":"Universitaire Ziekenhuizen Leuven, KU Leuven","doi-asserted-by":"publisher","award":["RT0817"],"award-info":[{"award-number":["RT0817"]}],"id":[{"id":"10.13039\/501100010648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010648","name":"Universitaire Ziekenhuizen Leuven, KU Leuven","doi-asserted-by":"publisher","award":["RT0817"],"award-info":[{"award-number":["RT0817"]}],"id":[{"id":"10.13039\/501100010648","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stichting Me To You"},{"name":"David Mason award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast-implant associated (BIA) lymphoma is an infrequent type of cancer occurring in the fluid and fibrous capsule around a textured breast implant. Recently, both the 2022 WHO 5th edition classification of Haematological tumours (WHO HAEM5) and 2022 International Consensus Classification of Mature Lymphoid Neoplasms (22ICC), recognized breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) as a definitive entity, defined as a mature CD30-positive T-cell lymphoma, confined by a fibrous capsule, in a breast implant setting. Only few B-cell lymphomas have been reported in the literature to be associated with breast implants. Here we report two EBV-positive Diffuse Large B-cell lymphomas (EBV\u2009+\u2009DLBCL) in relation to a breast implant, both expressing CD30 as well as EBV latency type 3. Both lesions were considered as DLBCL associated with chronic inflammation (CI-DLBCL), but one presented as a 7\u00a0cm solid mass, while the other presented as a fibrin-associated DLBCL (FA-DLBCL) in an HIV patient. Clinically, both are in complete remission 6\u00a0months or longer after capsulectomy and graft removal, without additional chemotherapy.<\/jats:p>\n                  <jats:p>Such cases, characterized by large CD30-positive cells, can easily be misdiagnosed as BIA-ALCL if the cell of origin is not further established. Therefore, a diagnostic panel including lineage-specific B-and T-cell markers and EBER in situ hybridization is essential to recognize this rare entity, to understand lymphomagenesis, to predict outcome and to\u00a0define clinical approach.<\/jats:p>","DOI":"10.1186\/s13000-023-01337-5","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T04:02:32Z","timestamp":1682395352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?"],"prefix":"10.1186","volume":"18","author":[{"given":"Johanna","family":"Vets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Marcelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Schepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaliva","family":"Dorreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Vanwalleghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Gieraerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Meylaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lesaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Put","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Snauwaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"De Paepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"1337_CR1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140:1229\u201353.","journal-title":"Blood"},{"key":"1337_CR2","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB de O, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720\u201348(2022)","DOI":"10.1038\/s41375-022-01620-2"},{"key":"1337_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/asj\/sjy331","volume":"39","author":"MW Clemens","year":"2019","unstructured":"Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthetic Surg J. 2019;39:S3-13.","journal-title":"Aesthetic Surg J"},{"key":"1337_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<287::AID-PATH932>3.0.CO;2-Q","volume":"183","author":"C Copie-Bergman","year":"1997","unstructured":"Copie-Bergman C, Niedobitek G, Mangham DC, Selves J, Baloch K, Diss TC, et al. Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation. J Pathol. 1997;183:287\u201392.","journal-title":"J Pathol"},{"key":"1337_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/01.pap.0000194627.50878.02","volume":"12","author":"K Aozasa","year":"2005","unstructured":"Aozasa K, Takakuwa T, Nakatsuka S. Pyothorax-Associated Lymphoma. Adv Anat Pathol. 2005;12:324\u201331.","journal-title":"Adv Anat Pathol"},{"key":"1337_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/PAS.0000000000000775","volume":"41","author":"DF Boyer","year":"2017","unstructured":"Boyer DF, Mckelvie PA, De LL, Edlefsen KL, Ko Y, Aberman ZA, et al. Fibrin-associated EBV-positive Large B-Cell Lymphoma. Am J Surg Pathol. 2017;41:299\u2013312.","journal-title":"Am J Surg Pathol"},{"key":"1337_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/his.13336","volume":"71","author":"J Yan","year":"2017","unstructured":"Yan J, Luo D, Zhang F, He J, Yao S, Luo X, et al. Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour. Histopathology. 2017;71:951\u20139.","journal-title":"Histopathology"},{"key":"1337_CR8","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/s41379-021-00863-1","volume":"34","author":"LJ Medeiros","year":"2021","unstructured":"Medeiros LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, Vega F, Feldman AL, et al. Epstein\u2013Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship. Mod Pathol. 2021;34:2154\u201367.","journal-title":"Mod Pathol"},{"key":"1337_CR9","doi-asserted-by":"publisher","first-page":"E412","DOI":"10.3324\/haematol.2019.232355","volume":"105","author":"SM Rodr\u00edguez-Pinilla","year":"2020","unstructured":"Rodr\u00edguez-Pinilla SM, Garc\u00eda FJS, Balagu\u00e9 O, Rodr\u00edguez-Justo M, Piris M\u00c1. Breast implant-associated Epstein-Barr virus-positive large B-cell lymphomas: a report of three cases. Haematologica. 2020;105:E412\u20134.","journal-title":"Haematologica"},{"key":"1337_CR10","first-page":"2004","volume":"35","author":"L Mescam","year":"2020","unstructured":"Mescam L, Camus V, Schiano J-M, Ad\u00e9la\u00efde J, Picquenot J-M, Guille A, et al. EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas. Blood. 2020;35:2004\u20139.","journal-title":"Blood"},{"key":"1337_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153589","volume":"226","author":"S Morgan","year":"2021","unstructured":"Morgan S, Tremblay-LeMay R, Lipa JE, Sur M, Delabie J, Imrie K, et al. Breast implant-associated EBV-positive diffuse large B-cell lymphoma: Two case reports and literature review. Pathol Res Pract. 2021;226: 153589.","journal-title":"Pathol Res Pract"},{"key":"1337_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.pathol.2020.09.022","volume":"53","author":"C Khoo","year":"2021","unstructured":"Khoo C, McTigue C, Hunter-Smith DJ, Walker P. EBV positive fibrin\/chronic inflammation associated diffuse large B-cell lymphoma: an incidental finding associated with a breast implant. Pathology. 2021;53:673\u20135.","journal-title":"Pathology"},{"key":"1337_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/SAP.0000000000002537","volume":"86","author":"CM Malata","year":"2021","unstructured":"Malata CM, Madada-Nyakauru RN, Follows G, Wright P. Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma Identified in a Breast Implant Capsule: A New Breast Implant-Associated Lymphoma? Ann Plast Surg. 2021;86:383\u20136.","journal-title":"Ann Plast Surg"},{"key":"1337_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/his.14372","volume":"79","author":"M Mansy","year":"2021","unstructured":"Mansy M, Wotherspoon AC, El-Sharkawi D, Cunningham D, Wren D, Sharma B, et al. Fibrin-associated diffuse large B-cell lymphoma misdiagnosed as breast implant-associated anaplastic large-cell lymphoma. Histopathology. 2021;79:269\u201371.","journal-title":"Histopathology"},{"key":"1337_CR15","first-page":"6647","volume":"47","author":"RL King","year":"2020","unstructured":"King RL, Goodlad JR, Calaminici M, Dotlic S, Montes-Moreno S, Oschlies I, et al. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis. Virchows Arch. 2020;47:6647\u201365.","journal-title":"Virchows Arch"},{"key":"1337_CR16","first-page":"53","volume":"52","author":"N Sukswai","year":"2020","unstructured":"Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ. Diffuse large B-cell lymphoma variants: an update. Pathology Pathology. 2020;52:53\u201367.","journal-title":"Pathology Pathology"},{"key":"1337_CR17","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3324\/haematol.2019.245860","volume":"106","author":"N Oishi","year":"2021","unstructured":"Oishi N, Hundal T, Phillips JL, Dasari S, Hu G, Viswanatha DS, et al. Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma. Haematologica. 2021;106:1714\u201324.","journal-title":"Haematologica"},{"key":"1337_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/his.14666","volume":"81","author":"N Oishi","year":"2022","unstructured":"Oishi N, Feldman AL. CA9 expression in breast implant-associated anaplastic large cell lymphoma presenting in a lymph node. Histopathology. 2022;81:270\u20132.","journal-title":"Histopathology"},{"key":"1337_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/PAS.0000000000000985","volume":"42","author":"MC Ferrufino-Schmidt","year":"2018","unstructured":"Ferrufino-Schmidt MC, Jeffrey Medeiros L, Liu H, Clemens MW, Hunt KK, Laurent C, et al. Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients with Breast Implant-associated Anaplastic Large Cell Lymphoma. Am J Surg Pathol. 2018;42:293\u2013305.","journal-title":"Am J Surg Pathol"},{"key":"1337_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/asj\/sjw259","volume":"37","author":"MW Clemens","year":"2017","unstructured":"Clemens MW, Horwitz SM. NCCN Consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma. Aesthetic Surg J. 2017;37:285\u20139.","journal-title":"Aesthetic Surg J"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-023-01337-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T04:06:07Z","timestamp":1682395567000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-023-01337-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1186\/s13000-023-01337-5","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee (S-55498) and conducted according to the principles of the Declaration of Helsinki. Informed consent from the patient is obtained according to the hospital policy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"52"}}